{"version":"1.0","type":"rich","provider_name":"EbookNetworking","provider_url":"https://www.ebooknetworking.net","title":"Isis Pharmaceuticals' Genetrove division and the R.W. Johnson Pharmaceutical Research Institute initiate antisense target validation program.(Brief Article): An article from: BIOTECH Patent News","author_name":"","thumbnail_url":"https://www.ebooknetworking.net/books/noimage.jpg","thumbnail_width":330,"thumbnail_height":500,"html":"<a href=\"https://www.ebooknetworking.net/books_detail-B0008J11TM.html\">Isis Pharmaceuticals&#039; Genetrove division and the R.W. Johnson Pharmaceutical Research Institute initiate antisense target validation program.(Brief Article): An article from: BIOTECH Patent News</a>","width":400,"height":300}